Human metapneumovirus: Lessons learned over the first decade

Clinical Microbiology Reviews

Volumn 24, Issue 4, 2011, Pages 734-754

  Schildgen, Verena ^a   van den Hoogen, Bernadette ^b   Fouchier, Ron ^b   Tripp, Ralph A ^c   Alvarez, Rene ^d   Manoha, Catherine ^e   Williams, John ^f   Schildgen, Oliver ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF GEORGIA   (United States)

^d Applied Laboratory Sciences Division ^*  (United States)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; POLYCLONAL HUMAN IMMUNOGLOBULIN; RIBAVIRIN; UNCLASSIFIED DRUG; VACCINE;

CELL CULTURE; CELLULAR IMMUNITY; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOLUTIONARY RATE; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; FERRET; FLUORESCENT ANTIBODY TECHNIQUE; HAMSTER; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; METAPNEUMOVIRUS; METAPNEUMOVIRUS INFECTION; MIXED INFECTION; MOLECULAR DIAGNOSIS; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; SIGMODON FULVIVENTER; SIGMODON HISPIDUS; STAINING; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; HUMANS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS;

HUMAN METAPNEUMOVIRUS;

EID: 80053579787     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00015-11     Document Type: Note

References (262)

1. Abdullah Brooks, W., et al. 2007. Human metapneumovirus infection among children, Bangladesh. Emerg. Infect. Dis. 13:1611-1613.
2. Aberle, J. H., S. W. Aberle, M. Redlberger-Fritz, M. J. Sandhofer, and T. Popow-Kraupp. 2010. Human metapneumovirus subgroup changes and seasonality during epidemics. Pediatr. Infect. Dis. J. 29:1016-1018.
3. Aberle, S. W., J. H. Aberle, M. J. Sandhofer, E. Pracher, and T. Popow-Kraupp. 2008. Biennial spring activity of human metapneumovirus in Austria. Pediatr. Infect. Dis. J. 27:1065-1068.
4. Agapov, E., K. C. Sumino, M. Gaudreault-Keener, G. A. Storch, and M. J. Holtzman. 2006. Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J. Infect. Dis. 193:396-403.
5. Albuquerque, M. C., et al. 2009. Novel respiratory virus infections in children, Brazil. Emerg. Infect. Dis. 15:806-808.
6. Ali, S. A., et al. Human metapneumovirus in hospitalized children in Amman, Jordan. J. Med. Virol. 82:1012-1016.
7. Alvarez, R., K. S. Harrod, W. J. Shieh, S. Zaki, and R. A. Tripp. 2004. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 78:14003-14011.
8. Alvarez, R., and R. A. Tripp. 2005. The immune response to human etapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J. Virol. 79:5971-5978.
9. Arnott, A., et al. 1 February 2011. Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009. Infect. Genet. Evol.
10. Bach, N., et al. 2004. Acute respiratory tract infections due to a human metapneumovirus in children: descriptive study and comparison with respiratory syncytial virus infections. Arch. Pediatr. 11:212-215.
11. Balada-Llasat, J. M., H. LaRue, C. Kelly, L. Rigali, and P. Pancholi. 2011. Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults. J. Clin. Virol. 50:42-45.
12. Bao, X., et al. 2008. Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J. Virol. 82:8224-8229.
13. Bao, X., et al. 2008. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog. 4:e1000077.
14. Bao, X., et al. 2007. Airway epithelial cell response to human metapneumovirus infection. Virology 368:91-101.
15. Bao, X., et al. 2008. Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis. Virology 374:114-127.
16. Bastien, N., et al. 2003. Human metapneumovirus infection in the Canadian population. J. Clin. Microbiol. 41:4642-4646.
17. Bäyon-Auboyer, M. H., C. T. D. Arnauld, and N. Eterradossi. 2000. Nucleotide sequences of the F, L and G protein genes of two non-A/non-B avian pneumoviruses (APV) reveal a novel APV subgroup. J. Gen. Virol. 81: 2723-2733.
18. Beneri, C., C. C. Ginocchio, R. Manji, and S. Sood. 2009. Comparison of clinical features of pediatric respiratory syncytial virus and human metapneumovirus infections. Infect. Control Hosp. Epidemiol. 30:1240-1241.
19. Bermingham, A., and P. L. Collins. 1999. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. U. S. A. 96:11259-11264.
20. Bharaj, P., et al. 2009. Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007. Virol. J. 6:89.
21. Biacchesi, S., et al. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J. Virol. 79:12608-12613.
22. Biacchesi, S., et al. 2006. Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates. J. Virol. 80:5798-5806.
23. Biacchesi, S., et al. 2004. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321:247-259.
24. Biacchesi, S., et al. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J. Virol. 78:12877-12887.
25. Blanco, J. C., M. S. Boukhvalova, K. A. Shirey, G. A. Prince, and S. N. Vogel. New insights for development of a safe and protective RSV vaccine. Hum. Vaccin. 6:482-492.
26. Boeckh, M., V. Erard, D. Zerr, and J. Englund. 2005. Emerging viral infections after hematopoietic cell transplantation. Pediatr. Transplant. 9(Suppl. 7):48-54.
27. Boivin, G., et al. 2002. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 186: 1330-1334.
28. Boivin, G., et al. 2003. Human metapneumovirus infections in hospitalized children. Emerg. Infect. Dis. 9:634-640.
29. Boivin, G., et al. 2007. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin. Infect. Dis. 44:1152-1158.
30. Bosis, S., et al. 2005. Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J. Med. Virol. 75:101-104.
31. Boukhvalova, M. S., G. A. Prince, and J. C. Blanco. 2009. The cotton rat model of respiratory viral infections. Biologicals 37:152-159.
32. Brien, J., J. L. Uhrlaub, A. Hirsch, C. A. Wiley, and J. Nikolich-Zugich. 2009. Key role of T cell defects in age-related vulnerability to West Nile virus. J. Exp. Med. 206:2735-2745.
33. Bruijnesteijn van Coppenraet, L. E., et al. 2010. Comparison of two commercial molecular assays for simultaneous detection of respiratory viruses in clinical samples using two automatic electrophoresis detection systems. J. Virol. Methods 169:188-192.
34. Buchholz, U. J., et al. 2005. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J. Virol. 79:6588-6597.
35. Burton, R. E. W., et al. 2010. A microfluid chip-compatible bioassay based on single-molecule detection with high sensitivity and multiplexing. Lab Chip 10:843-851.
36. Byus, S. B., et al. 1989. Swollen head syndrome in chicken: a preliminary report on the isolation of a possible aetiological agent. J. S. Afr. Vet. Assoc. 60:221-222.
37. Cane, P. A., B. G. van den Hoogen, S. Chakrabarti, C. D. Fegan, and A. D. Osterhaus. 2003. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant. 31:309-310.
38. Caracciolo, S., et al. 2008. Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features. Pediatr. Infect. Dis. J. 27:406-412.
39. Carneiro, B. M., et al. 2009. Detection of all four human metapneumovirus subtypes in nasopharyngeal specimens from children with respiratory disease in Uberlandia, Brazil. J. Med. Virol. 81:1814-1818.
40. Carr, M. J., et al. 2008. Molecular epidemiology of human metapneumovirus in Ireland. J. Med. Virol. 80:510-516.
41. Chen, K. F., et al. 2011. Reverse transcription polymerase chain reaction and electrospray ionization mass spectrometry for identifying acute viral upper respiratory tract infections. Diagn. Microbiol. Infect. Dis. 69:179-186.
42. Chiu, C. Y., et al. 2007. Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. J. Clin. Microbiol. 45:2340-2343.
43. Chung, J. Y., T. H. Han, S. W. Kim, and E. S. Hwang. 2008. Genotype variability of human metapneumovirus, South Korea. J. Med. Virol. 80: 902-905.
44. Chung, J. Y., T. H. Han, S. W. Kim, and E. S. Hwang. 2007. Respiratory picornavirus infections in Korean children with lower respiratory tract infections. Scand. J. Infect. Dis. 39:250-254.
45. Collins, P. L., M. G. Hill, J. Cristina, and H. Grosfeld. 1996. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negativestrand RNA virus. Proc. Natl. Acad. Sci. U. S. A. 93:81-85.
46. Cseke, G., et al. 2009. Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc. Natl. Acad. Sci. U. S. A. 106:1566-1571.
47. Cseke, G., et al. 2007. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol. 81:698-707.
48. Cuevas, L. E., et al. 2003. Human metapneumovirus and respiratory syncytial virus, Brazil. Emerg. Infect. Dis. 9:1626-1628.
49. Darniot, M., T. Petrella, S. Aho, P. Pothier, and C. Manoha. 2005. Immune response and alteration of pulmonary function after primary human metapneumovirus (hMPV) infection of BALB/c mice. Vaccine 23:4473-4480.
50. Darniot, M., et al. 2009. Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J. Virol. 83:3323-3332.
51. David, P., D. Hirschwerk, S. Goldberg, and C. Ginocchio. 2009. Acute pericarditis caused by human metapneumovirus. Infect. Dis. Clin. Pract. 17:283-285.
52. Debiaggi, M., et al. 2006. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J. Infect. Dis. 194:474-478.
53. de Graaf, M., et al. 2008. Specificity and functional interaction of the polymerase complex proteins of human and avian metapneumoviruses. J. Gen. Virol. 89:975-983.
54. de Graaf, M., et al. 2007. An improved plaque reduction virus neutralization assay for human metapneumovirus. J. Virol. Methods 143:169-174.
55. de Graaf, M., A. D. Osterhaus, R. A. Fouchier, and E. C. Holmes. 2008. Evolutionary dynamics of human and avian metapneumoviruses. J. Gen. Virol. 89:2933-2942.
56. de Graaf, M., et al. 2009. Fusion protein is the main determinant of etapneumovirus host tropism. J. Gen. Virol. 90:1408-1416.
57. de Graaf, M. H. S., et al. 2009. Metapneumovirus; determinants of host range and replication. Erasmus University Rotterdam, Rotterdam, The Netherlands.
58. de Swart, R. L., et al. 2007. Immunization of macaques with formalininactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25:8518-8528.
59. DeVincenzo, J. P., R. L. Hirsch, R. J. Fuentes, and F. H. Top, Jr. 2000. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation-a compassionate use experience. Bone Marrow Transplant. 25:161-165.
60. Dinwiddie, D. L., and K. S. Harrod. 2008. Human metapneumovirus inhib-its IFN-alpha signaling through inhibition of STAT1 phosphorylation. Am. J. Respir. Cell Mol. Biol. 38:661-670.
61. Ditt, V., J. Lusebrink, R. L. Tillmann, V. Schildgen, and O. Schildgen. 2011. Respiratory infections by HMPV and RSV are clinically indistinguishable but induce different host response in aged individuals. PLoS One 6:e16314.
62. Dollner, H., K. Risnes, A. Radtke, and S. A. Nordbo. 2004. Outbreak of human metapneumovirus infection in Norwegian children. Pediatr. Infect. Dis. J. 23:436-440.
63. Don, M., M. Korppi, F. Valent, R. Vainionpaa, and M. Canciani. 2008. Human metapneumovirus pneumonia in children: results of an Italian study and mini-review. Scand. J. Infect. Dis. 40:821-826.
64. Drews, S. J., et al. 2008. Use of the Seeplex RV detection kit for surveillance of respiratory viral outbreaks in Toronto, Ontario, Canada. Ann. Clin. Lab. Sci. 38:376-379.
65. Ebihara, T., et al. 2004. Early reinfection with human metapneumovirus in an infant. J. Clin. Microbiol. 42:5944-5946.
66. Ebihara, T., et al. 2004. Human metapneumovirus infection in Japanese children. J. Clin. Microbiol. 42:126-132.
67. Ebihara, T., et al. 2004. Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus. J. Med. Virol. 72:304-306.
68. Englund, J. A., et al. 2006. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 144:344-349.
69. Escobar, C., et al. 2009. Genetic variability of human metapneumovirus isolated from Chilean children, 2003-2004. J. Med. Virol. 81:340-344.
70. Esper, F., D. Boucher, C. Weibel, R. A. Martinello, and J. S. Kahn. 2003. Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 111:1407-1410.
71. Esper, F., et al. 2004. A 1-year experience with human metapneumovirus in children aged 5 years. J. Infect. Dis. 189:1388-1396.
72. Fabbiani, M., et al. 2009. Epidemiological and clinical study of viral respiratory tract infections in children from Italy. J. Med. Virol. 81:750-756.
73. Falsey, A. R., M. C. Criddle, and E. E. Walsh. 2006. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J. Clin. Virol. 35:46-50.
74. Falsey, A. R., D. Erdman, L. J. Anderson, and E. E. Walsh. 2003. Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 187:785-790.
75. Falsey, A. R., M. A. Formica, J. J. Treanor, and E. E. Walsh. 2003. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J. Clin. Microbiol. 41:4160-4165.
76. Falsey, A. R., M. A. Formica, and E. E. Walsh. 2009. Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus. J. Clin. Virol. 46:314-317.
77. Fearns, R., and P. L. Collins. 1999. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J. Virol. 73:5852-5864.
78. Franquet, T., et al. 2005. Human metapneumovirus infection in hematopoietic stem cell transplant recipients: high-resolution computed tomography findings. J. Comput. Assist. Tomogr. 29:223-227.
79. Freymouth, F., et al. 2003. Presence of the new human metapneumovirus in French children with bronchiolitis. Pediatr. Infect. Dis. J. 22:92-94.
80. Fuenzalida, L., et al. 2010. Usefulness of two new methods for diagnosing metapneumovirus infections in children. Clin. Microbiol. Infect. 16:1663-1668.
81. Furuse, Y., et al. Detection of novel respiratory viruses from influenza-like illness in the Philippines. J. Med. Virol. 82:1071-1074.
82. Galiano, M., et al. 2004. Evidence of human metapneumovirus in children in Argentina. J. Med. Virol. 72:299-303.
83. Garbino, J., et al. 2008. Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS 22:701-705.
84. Garcia-Garcia, M. L., et al. 2007. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr. Pulmonol. 42:458-464.
85. Garcia-Garcia, M. L., et al. 2006. Human metapneumovirus infections in hospitalised infants in Spain. Arch. Dis. Child. 91:290-295.
86. Garcia-Garcia, M. L., et al. 2006. Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain. Pediatr. Pulmonol. 41:863-871.
87. Garcia-Sastre, A. 2006. Antiviral response in pandemic influenza viruses. Emerg. Infect. Dis. 12:44-47.
88. Gaunt, E., E. C. McWilliam-Leitch, K. Templeton, and P. Simmonds. 2009. Incidence, molecular epidemiology and clinical presentations of human metapneumovirus; assessment of its importance as a diagnostic screening target. J. Clin. Virol. 46:318-324.
89. Gerna, G., et al. 2005. Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons. Brief report. Arch. Virol. 150:2365-2375.
90. Ginocchio, C. C., R. Manji, M. Lotlikar, and F. Zhang. 2008. Clinical evaluation of NucliSENS magnetic extraction and NucliSENS analyte-specific reagents for real-time detection of human metapneumovirus in pediatric respiratory specimens. J. Clin. Microbiol. 46:1274-1280.
91. Gioula, G., D. Chatzidimitriou, A. Melidou, M. Exindari, and V. Kyriazopoulou- Dalaina. 2010. Contribution of human metapneumovirus to influenza-like infections in North Greece, 2005-2008. Euro. Surveill. 15:19499.
92. Gould, P. S., and A. J. Easton. 2007. Coupled translation of the second open reading frame of M2 mRNA is sequence dependent and differs significantly within the subfamily Pneumovirinae. J. Virol. 81:8488-8496.
93. Goutagny, N., et al. 2010. Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J. Immunol. 184:1168-1179.
94. Gray, G. C., et al. 2006. Multi-year study of human metapneumovirus infection at a large US midwestern medical referral center. J. Clin. Virol. 37:269-276.
95. Gray, G. C., et al. 2006. Human metapneumovirus, Peru. Emerg. Infect. Dis. 12:347-350.
96. Greensill, J., et al. 2003. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg. Infect. Dis. 9:372-375.
97. Guerrero-Plata, A., et al. 2005. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J. Virol. 79:10190-10199.
98. Guerrero-Plata, A., et al. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 34:320-329.
99. Guerrero-Plata, A., D. Kolli, C. Hong, A. Casola, and R. P. Garofalo. 2009. Subversion of pulmonary dendritic cell function by paramyxovirus infections. J. Immunol. 182:3072-3083.
100. Hamelin, M. E., Y. Abed, and G. Boivin. 2004. Human metapneumovirus: a new player among respiratory viruses. Clin. Infect. Dis. 38:983-990.
101. Hamelin, M. E., et al. 2005. Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin. Infect. Dis. 41:498-502.
102. Hamelin, M. E., G. A. Prince, and G. Boivin. 2006. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob. Agents Chemother. 50:774-777.
103. Hamelin, M. E., G. A. Prince, A. M. Gomez, R. Kinkead, and G. Boivin. 2006. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis. 193:1634-1642.
104. Hamelin, M. E., et al. 2005. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J. Virol. 79:8894-8903.
105. Heininger, U., A. T. Kruker, J. Bonhoeffer, and U. B. Schaad. 2009. Human metapneumovirus infections-biannual epidemics and clinical findings in children in the region of Basel, Switzerland. Eur. J. Pediatr. 168:1455-1460.
106. Herd, K. A., et al. 2006. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J. Virol. 80:2034-2044.
107. Herd, K. A., M. D. Nissen, P. M. Hopkins, T. P. Sloots, and R. W. Tindle. 2008. Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. J. Infect. Dis. 197:584-592.
108. Herfst, S., et al. 2004. Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J. Virol. 78:8264-8270.
109. Herfst, S., et al. 2008. Generation of temperature-sensitive human etapneumovirus strains that provide protective immunity in hamsters. J. Gen. Virol. 89:1553-1562.
110. Herfst, S., et al. 2007. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J. Gen. Virol. 88:2702-2709.
111. Herfst, S., and R. A. Fouchier. 2008. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections. J. Clin. Virol. 41:49-52.
112. Herfst, S., et al. 2008. Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J. Virol. 82:8891-8895.
113. High, K. P. 2005. Pneumonia in older adults. New categories add complexity to diagnosis and care. Postgrad. Med. 118:18-20, 25-28.
114. Honda, H., et al. 2006. Outbreak of human metapneumovirus infection in elderly inpatients in Japan. J. Am. Geriatr. Soc. 54:177-180.
115. Hopkins, P., et al. 2008. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncitial virus. Am. J. Respir. Crit. Care Med. 178:876-881.
116. Huck, B., et al. 2006. Novel human metapneumovirus sublineage. Emerg. Infect. Dis. 12:147-150.
117. Jpma, F. F., et al. 2004. Human metapneumovirus infection in hospital referred South African children. J. Med. Virol. 73:486-493.
118. Jartti, T., B. van den Hoogen, R. P. Garofalo, A. D. Osterhaus, and O. Ruuskanen. 2002. Metapneumovirus and acute wheezing in children. Lancet 360:1393-1394.
119. Jenkins, G. M. R., et al. 2002. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 54:156-165.
120. Jiang, J., et al. 2009. Limited expansion of virus-specific CD8 T cells in the aged environment. Mech. Ageing Dev. 130:713-721.
121. Jiang, T., et al. 2009. CpG oligodeoxynucleotides protect against the H1N1 pandemic influenza virus infection in a murine model. Antiviral Res. 89: 124-126.
122. Jiang, T. J., et al. 2009. Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with pandemic H1N1 swine-origin influenza A infection. Clin. Immunol. 137:303-310.
123. Jokela, P., H. Piiparinen, K. Luiro, and M. Lappalainen. 2010. Detection of human metapneumovirus and respiratory syncytial virus by duplex realtime RT-PCR assay in comparison with direct fluorescent assay. Clin. Microbiol. Infect. 16:1568-1573.
124. Kahn, J. S., M. J. Schnell, L. Buonocore, and J. K. Rose. 1999. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 254:81-91.
125. Kaida, A., et al. 2006. Seasonal distribution and phylogenetic analysis of human metapneumovirus among children in Osaka City, Japan. J. Clin. Virol. 35:394-399.
126. Kawai, T. A. S. 2005. Pathogen recognotion with Toll-like receptors. Curr. Opin. Immunol. 17:338-344.
127. Kaye, M., S. Skidmore, H. Osman, M. Weinbren, and R. Warren. 2006. Surveillance of respiratory virus infections in adult hospital admissions using rapid methods. Epidemiol. Infect. 134:792-798.
128. Kolli, D., et al. 2008. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 82:8560-8569.
129. Konig, B., et al. 2004. Prospective study of human metapneumovirus infection in children less than 3 years of age. J. Clin. Microbiol. 42:4632-4635.
130. Kuiken, T., et al. 2004. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am. J. Pathol. 164:1893-1900.
131. Laguna-Torres, V. A., et al. 2011. Influenza and other respiratory viruses in three Central American countries. Influenza Other Respi. Viruses 5:123-134.
132. Laham, F. R., et al. 2004. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J. Infect. Dis. 189:2047-2056.
133. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
134. Lamb, R. A., and T. S. Jardetzky. 2007. Structural basis of viral invasion: lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 17:427-436.
135. Lamb, R. A. P., and G. D. Parks. 2007. Paramyxoviridae: the viruses and their replication, p. 1449-1456. In D. M. Knipe et al. (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
136. Landry, M. L., S. Cohen, and D. Ferguson. 2008. Prospective study of human metapneumovirus detection in clinical samples by use of Light Diagnostics direct immunofluorescence reagent and real-time PCR. J. Clin. Microbiol. 46:1098-1100.
137. Landry, M. L., D. Ferguson, S. Cohen, T. C. Peret, and D. D. Erdman. 2005. Detection of human metapneumovirus in clinical samples by immunofluorescence staining of shell vial centrifugation cultures prepared from three different cell lines. J. Clin. Microbiol. 43:1950-1952.
138. Larcher, C., et al. 2005. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J. Heart Lung Transplant. 24:1891-1901.
139. Larcher, C., et al. 2008. Comparison of human metapneumovirus genotypes from the province of Bolzano in northern Italy with strains from surrounding regions in Italy and Austria. Jpn. J. Infect. Dis. 61:154-156.
140. Lazar, I., et al. 2004. Human metapneumovirus and severity of respiratory syncytial virus disease. Emerg. Infect. Dis. 10:1318-1320.
141. Leung, J., F. Esper, C. Weibel, and J. S. Kahn. 2005. Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J. Clin. Microbiol. 43:1213-1219.
142. Liao, S., et al. 2008. Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J. Gen. Virol. 89:1978-1986.
143. Liu, L., N. Bastien, and Y. Li. 2007. Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein. J. Virol. 81:13435-13443.
144. Liu, L., N. Bastien, F. Sidaway, E. Chan, and Y. Li. 2007. Seroprevalence of human metapneumovirus (hMPV) in the Canadian province of Saskatchewan analyzed by a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay. J. Med. Virol. 79:308-313.
145. Ljubin-Sternak, S., et al. 2008. Detection of genetic lineages of human metapneumovirus in Croatia during the winter season 2005/2006. J. Med. Virol. 80:1282-1287.
146. Ljubin Sternak, S., T. Vilibic Cavlek, A. R. Falsey, E. E. Walsh, and G. Mlinaric Galinovic. 2006. Serosurvey of human metapneumovirus infection in Croatia. Croat. Med. J. 47:878-881.
147. Loo, L. H., et al. 2007. Human metapneumovirus in children, Singapore. Emerg. Infect. Dis. 13:1396-1398.
148. Louie, J. K., et al. 2007. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J. Infect. Dis. 196:705-708.
149. Lu, G., et al. Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China. Virol. J. 8:62.
150. Luchsinger, V., C. Escobar, and L. F. Avendano. 2005. Detection of human metapneumovirus in children hospitalized for acute lower respiratory infection in Santiago, Chile. Rev. Med. Chil. 133:1059-1064.
151. Ludewick, H. P., et al. 2005. Human metapneumovirus genetic variability, South Africa. Emerg. Infect. Dis. 11:1074-1078.
152. Lusebrink, J., et al. High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin. Vaccine Immunol. 17:481-484.
153. Mackay, I. M., et al. 2006. Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. J. Infect. Dis. 193:1630-1633.
154. MacPhail, M., et al. 2004. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J. Gen. Virol. 85:1655-1663.
155. Madhi, S. A., H. Ludewick, Y. Abed, K. P. Klugman, and G. Boivin. 2003. Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin. Infect. Dis. 37:1705-1710.
156. Madhi, S. A., et al. 2007. Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr. Infect. Dis. J. 26:693-699.
157. Maertzdorf, J., et al. 2004. Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J. Clin. Microbiol. 42:981-986.
158. Maggi, F., et al. 2003. Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J. Clin. Microbiol. 41:2987-2991.
159. Manoha, C., S. Espinosa, S. L. Aho, F. Huet, and P. Pothier. 2007. Pidemiological and clinical features of hMPV, RSV and RVs infections in young children. J. Clin. Virol. 38:221-226.
160. Mao, H. W., X. Q. Yang, and X. D. Zhao. 2008. Characterization of human metapneumoviruses isolated in Chongqing, China. Chin. Med. J. (Engl.) 121:2254-2257.
161. Martinello, R. A., M. D. Chen, C. Weibel, and J. S. Kahn. 2002. Correlation between respiratory syncytial virus genotype and severity of illness. J. Infect. Dis. 186:839-842.
162. Martinello, R. A., et al. 2006. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J. Infect. 53:248-254.
163. Martino, R., et al. 2005. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol. Blood Marrow Transplant. 11:781-796.
164. Mathisen, M., et al. 2009. RNA viruses in community-acquired childhood pneumonia in semi-urban Nepal; a cross-sectional study. BMC Med. 7:35.
165. Matsuzaki, Y., et al. 2008. Clinical impact of human metapneumovirus genotypes and genotype-specific seroprevalence in Yamagata, Japan. J. Med. Virol. 80:1084-1089.
166. Mazhul, L. A., O. Schildgen, E. I. Isaeva, and S. O. Viazov. 2007. Human metapneumovirus as a common cause of respiratory tract disease. Vopr. Virusol. 52:4-8.
167. McAdam, A. J., et al. 2004. Human metapneumovirus in children tested at a tertiary-care hospital. J. Infect. Dis. 190:20-26.
168. Melendi, G. A., et al. 2007. Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus. J. Virol. 81:11461-11467.
169. Mirazo, S., D. Ruchansky, A. Blanc, and J. Arbiza. 2005. Serologic evidence of human metapneumovirus circulation in Uruguay. Mem. Inst. Oswaldo Cruz 100:715-718.
170. Mok, H., et al. 2008. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J. Virol. 82:11410-11418.
171. Monto, A. S. 2002. Epidemiology of viral respiratory infections. Am. J. Med. 112(Suppl. 6A):4S-12S.
172. Mullins, J. A., et al. 2004. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg. Infect. Dis. 10:700-705.
173. Nicholson, K. G., T. McNally, M. Silverman, P. Simons, and M. C. Zambon. 2003. Influenza-related hospitalizations among young children in Leicestershire. Pediatr. Infect. Dis. J. 22:S228-S230.
174. Nolte, F. S., et al. 2007. MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J. Clin. Microbiol. 45:2779-2786.
175. Okamoto, M., et al. 2010. Development and evaluation of a whole virus- based enzyme-linked immunosorbent assay for the detection of human metapneumovirus antibodies in human sera. J. Virol. Methods 164:24-29.
176. Oliveira, D. B., et al. 2009. Epidemiology and genetic variability of human metapneumovirus during a 4-year-long study in Southeastern Brazil. J. Med. Virol. 81:915-921.
177. Olmsted, R. A., et al. 1986. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sci. U. S. A. 83:7462-7466.
178. Ordas, J., et al. 2006. Role of metapneumovirus in viral respiratory infections in young children. J. Clin. Microbiol. 44:2739-2742.
179. Osbourn, M., K. A. McPhie, V. M. Ratnamohan, D. E. Dwyer, and D. N. Durrheim. 2009. Outbreak of human metapneumovirus infection in a residential aged care facility. Commun. Dis. Intell. 33:38-40.
180. Pavlin, J. A., et al. 2008. Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. J. Infect. Dis. 198:836-842.
181. Peiris, J. S., et al. 2003. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg. Infect. Dis. 9:628-633.
182. Pelletier, G., P. Dery, Y. Abed, and G. Boivin. 2002. Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. Emerg. Infect. Dis. 8:976-978.
183. Pham, Q. N., et al. 2005. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J. Virol. 79:15114-15122.
184. Pitoiset, C., et al. 2010. Human metapneumovirus genotypes and severity of disease in young children (n 100) during a 7-year study in Dijon hospital, France. J. Med. Virol. 82:1782-1789.
185. Pizzorno, A., et al. Molecular detection and genetic variability of human metapneumovirus in Uruguay. J. Med. Virol. 82:861-865.
186. Po, J. L., E. M. Gardner, F. Anaraki, P. D. Katsikis, and D. Murasko. 2002. Age-associated decrease in virus-specific CD8 T lymphocytes during primary influenza infection. Mech. Ageing Dev. 123:1167-1181.
187. Rafiefard, F., Z. Yun, and C. Orvell. 2008. Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections in five epidemic seasons in Stockholm, Sweden, 2002-2006. J. Med. Virol. 80: 1631-1638.
188. Rawlinson, W. D., et al. 2003. Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. J. Infect. Dis. 187:1314-1318.
189. Raymond, F., et al. 2009. Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J. Clin. Microbiol. 47:743-750.
190. Raza, K., et al. 2007. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J. Heart Lung Transplant. 26:862-864.
191. Reijans, M., et al. 2008. RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses. J. Clin. Microbiol. 46:1232-1240.
192. Robinson, J. L., B. E. Lee, N. Bastien, and Y. Li. 2005. Seasonality and clinical features of human metapneumovirus infection in children in Northern Alberta. J. Med. Virol. 76:98-105.
193. Rohde, G., et al. 2005. Relevance of human metapneumovirus in exacerbations of COPD. Respir. Res. 6:150.
194. Russell, C. J., and L. E. Luque. 2006. The structural basis of paramyxovirus invasion. Trends Microbiol. 14:243-246.
195. Ryder, A. B., S. J. Tollefson, A. B. Podsiad, J. E. Johnson, and J. V. Williams. 2010. Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine 28:4145-4152.
196. Schickli, J. H., et al. 2008. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters. Virol. J. 5:69.
197. Schickli, J. H., J. Kaur, N. Ulbrandt, R. R. Spaete, and R. S. Tang. 2005. An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in Vero cells and does not alter tissue tropism in hamsters. J. Virol. 79:10678-10689.
198. Schildgen, O., T. Geikowski, T. Glatzel, J. Schuster, and A. Simon. 2005. Frequency of human metapneumovirus in the upper respiratory tract of children with symptoms of an acute otitis media. Eur. J. Pediatr. 164:400-401.
199. Schildgen, O., et al. 2004. New variant of the human metapneumovirus (HMPV) associated with an acute and severe exacerbation of asthma bronchiale. J. Clin. Virol. 31:283-288.
200. Schildgen, O., A. Simon, and J. Williams. 2007. Animal models for human metapneumovirus (HMPV) infections. Vet. Res. 38:117-126.
201. Schildgen, V., et al. 2010. Human HepG2 cells support respiratory syncytial virus and human metapneumovirus replication. J. Virol. Methods 163:74-81.
202. Schowalter, R. M., S. E. Smith, and R. E. Dutch. 2006. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J. Virol. 80:10931-10941.
203. Seal, B. S. S., et al. 2000. Fusion protein predicted amino acid sequence of the first US avian pneumovirus isolate and lack of heterogeneity among other US isolates. Virus Res. 66:139-147.
204. Semple, M. G., et al. 2005. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J. Infect. Dis. 191:382-386.
205. Seth, R. B. S., et al. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signalling protein that actrivates NF-kappa B and IRF-3. Cell 122:669-682.
206. Shanmukh, S., et al. 2008. Identification and classification of respiratory syncytial virus (RSV) strains by surface-enhanced Raman spectroscopy and multivariate statistical techniques. Anal. Bioanal. Chem. 390:1551-1555.
207. Singleton, R. J., et al. 2010. Viral respiratory infections in hospitalized and community control children in Alaska. J. Med. Virol. 82:1282-1290.
208. Skiadopoulos, M. H., et al. 2006. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345:492-501.
209. Skiadopoulos, M. H., et al. 2004. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 78:6927-6937.
210. Sloots, T. P., et al. 2006. Human metapneumovirus, Australia, 2001-2004. Emerg. Infect. Dis. 12:1263-1266.
211. Smith, E. C., A. Popa, A. Chang, C. Masante, and R. E. Dutch. 2009. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276:7217-7227.
212. Spetch, L., T. L. Bowlin, and A. Casola. 2008. Effect of NMSO3 treatment in a murine model of human metapneumovirus infection. J. Gen. Virol. 89:2709-2712.
213. Stout-Delgado, H. W., W. Du, A. C. Shirali, C. J. Booth, and D. Goldstein. 2009. Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection. Cell Host Microbe 6:446-456.
214. Sullender, W. M. 2000. Respiratory syncytial virus genetic and antigenic diversity. Clin. Microbiol. Rev. 13:1-15.
215. Sumino, K. C., et al. 2005. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J. Infect. Dis. 192:1052-1060.
216. Suzuki, A., et al. 2005. Detection of human metapneumovirus from children with acute otitis media. Pediatr. Infect. Dis. J. 24:655-657.
217. Takaoka, A. Y. H. 2006. Interferon signalling network in innate defense. Cell. Microbiol. 8:907-922.
218. Talavera, G. A., and N. E. Mezquita. 2007. Human metapneumovirus in children with influenza-like illness in Yucatan, Mexico. Am. J. Trop. Med. Hyg. 76:182-183.
219. Tang, R. S., et al. 2004. Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys. J. Virol. 78: 11198-11207.
220. Tang, R. S., et al. 2005. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23:1657-1667.
221. Tang, R. S., et al. 2003. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3 proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity. J. Virol. 77:10819-10828.
222. Tecu, C., et al. 2007. First detection of human metapneumovirus in children with respiratory infections in Romania. Roum. Arch. Microbiol. Immunol. 66:37-40.
223. Thammawat, S., T. A. Sadlon, P. G. Hallsworth, and D. L. Gordon. 2008. Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J. Virol. 82:11767-11774.
224. Thanasugarn, W., et al. 2003. Human metapneumovirus infection in Thai children. Scand. J. Infect. Dis. 35:754-756.
225. Tollefson, S. J., R. G. Cox, and J. V. Williams. 2010. Studies of culture conditions and environmental stability of human metapneumovirus. Virus Res. 151:54-59.
226. Ulbrandt, N. D., et al. 2006. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 80:7799-7806.
227. Ulloa-Gutierrez, R., et al. 2009. Human metapneumovirus in Costa Rica. Pediatr. Infect. Dis. J. 28:452-453.
228. van den Hoogen, B. G. 2007. Respiratory tract infection due to human metapneumovirus among elderly patients. Clin. Infect. Dis. 44:1159-1160.
229. van den Hoogen, B. G., T. M. Bestebroer, A. D. Osterhaus, and R. A. Fouchier. 2002. Analysis of the genomic sequence of a human metapneumovirus. Virology 295:119-132.
230. van den Hoogen, B. G., et al. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719-724.
231. van den Hoogen, B. G., et al. 2007. Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J. Gen. Virol. 88:1251-1259.
232. van den Hoogen, B. G., et al. 2004. Antigenic and genetic variability of human metapneumoviruses. Emerg. Infect. Dis. 10:658-666.
233. van den Hoogen, B. G., D. M. Osterhaus, and R. A. Fouchier. 2004. Clinical impact and diagnosis of human metapneumovirus infection. Pediatr. Infect. Dis. J. 23:S25-S32.
234. van den Hoogen, B. G., et al. 2003. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J. Infect. Dis. 188:1571-1577.
235. van Woensel, J. B., A. P. Bos, R. Lutter, J. W. Rossen, and R. Schuurman. 2006. Absence of human metapneumovirus co-infection in cases of severe respiratory syncytial virus infection. Pediatr. Pulmonol. 41:872-874.
236. Vargas, S. O., H. P. Kozakewich, A. R. Perez-Atayde, and A. J. McAdam. 2004. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr. Dev. Pathol. 7:478-486.
237. Viazov, S., F. Ratjen, R. Scheidhauer, M. Fiedler, and M. Roggendorf. 2003. High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J. Clin. Microbiol. 41:3043-3045.
238. Vicente, D., M. Montes, G. Cilla, and E. Perez-Trallero. 2004. Human metapneumovirus and chronic obstructive pulmonary disease. Emerg. Infect. Dis. 10:1338-1339.
239. Vicente, D., M. Montes, G. Cilla, E. G. Perez-Yarza, and E. Perez-Trallero. 2006. Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clin. Infect. Dis. 42:e111-e113.
240. Walsh, E. E., D. R. Peterson, and A. R. Falsey. 2008. Human metapneumovirus infections in adults: another piece of the puzzle. Arch. Intern. Med. 168:2489-2496.
241. Wang, H. C., et al. 2008. Co-circulating genetically divergent A2 human metapneumovirus strains among children in southern Taiwan. Arch. Virol. 153:2207-2213.
242. Wang, S. M., C. C. Liu, H. C. Wang, I. J. Su, and J. R. Wang. 2006. Human metapneumovirus infection among children in Taiwan: a comparison of clinical manifestations with other virus-associated respiratory tract infections. Clin. Microbiol. Infect. 12:1221-1224.
243. Weigl, J. A., et al. 2007. Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children. Eur. J. Pediatr. 166:957-966.
244. Wilkesmann, A., et al. 2006. Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur. J. Pediatr. 165:467-475.
245. Williams, J. V., et al. 2007. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J. Virol. 81:8315-8324.
246. Williams, J. V., et al. 2005. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis. 192:1149-1153.
247. Williams, J. V., et al. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350:443-450.
248. Williams, J. V., et al. 2005. A prospective study comparing human etapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis. 192:1061-1065.
249. Williams, J. V., et al. 2005. Human metapneumovirus infection in children hospitalized for wheezing. J. Allergy Clin. Immunol. 115:1311-1312.
250. Williams, J. V., S. J. Tollefson, J. E. Johnson, and J. E. Crowe, Jr. 2005. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J. Virol. 79:10944-10951.
251. Williams, J. V., S. J. Tollefson, S. Nair, and T. Chonmaitree. 2006. Association of human metapneumovirus with acute otitis media. Int. J. Pediatr. Otorhinolaryngol. 70:1189-1193.
252. Williams, J. V., et al. 2006. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J. Infect. Dis. 193:387-395.
253. Wolf, D. G., et al. 2006. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children. Pediatr. Infect. Dis. J. 25:320-324.
254. Wolf, D. G., Z. Zakay-Rones, A. Fadeela, D. Greenberg, and R. Dagan. 2003. High seroprevalence of human metapneumovirus among young children in Israel. J. Infect. Dis. 188:1865-1867.
255. Wyde, P. R., S. N. Chetty, A. M. Jewell, G. Boivin, and P. A. Piedra. 2003. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 60:51-59.
256. Wyde, P. R., S. N. Chetty, A. M. Jewell, S. L. Schoonover, and P. A. Piedra. 2005. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines. Antiviral Res. 66:57-66.
257. Xiao, N. G., et al. 2010. Prevalence and clinical and molecular characterization of human metapneumovirus in children with acute respiratory infection in China. Pediatr. Infect. Dis. J. 29:131-134.
258. Yang, C. F., et al. 2009. Genetic diversity and evolution of human etapneumovirus fusion protein over twenty years. Virol. J. 6:138.
259. Yim, K. C., et al. 2007. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25:5034-5040.
260. Zeng, L., et al. 2011. Association between human metapneumovirus eroprevalence and hypertension in elderly subjects in a long-term care facility. Hypertens. Res. 34:474-478.
261. Zhang, Q., X. Q. Yang, Y. Zhao, and X. D. Zhao. 2008. High seroprevalence of human metapneumovirus infection in children in Chongqing, China. Chin. Med. J. (Engl.) 121:2162-2166.
262. Zlateva, K. T., P. Lemey, A. M. Vandamme, and M. Van Ranst. 2004. Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup A: positively selected sites in the attachment G glycoprotein. J. Virol. 78:4675-4683.